Eyebright Medical Technology Beijing Co Ltd (688050) — Net Asset Quality Index
Eyebright Medical Technology Beijing Co Ltd (688050) has a Net Asset Quality Index of 65.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.76 Billion minus total liabilities of CN¥1.64 Billion yields net assets of CN¥3.13 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 688050 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Eyebright Medical Technology Beijing Co Ltd Net Asset Quality Index Over Time (2016–2025)
This chart shows how Eyebright Medical Technology Beijing Co Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 65.6%, representing net assets of CN¥3.13 Billion against total assets of CN¥4.76 Billion CNY. See 688050 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Eyebright Medical Technology Beijing Co Ltd (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Eyebright Medical Technology Beijing Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Eyebright Medical Technology Beijing Co .
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.4% | CN¥2.97 Billion | CN¥3.89 Billion | CN¥917.65 Million | ▲ +1.1 pp |
| 2024 | 75.3% | CN¥2.63 Billion | CN¥3.50 Billion | CN¥862.71 Million | ▼ -1.6 pp |
| 2023 | 76.9% | CN¥2.36 Billion | CN¥3.06 Billion | CN¥705.85 Million | ▼ -8.6 pp |
| 2022 | 85.6% | CN¥1.92 Billion | CN¥2.24 Billion | CN¥324.30 Million | ▲ +0.6 pp |
| 2021 | 85.0% | CN¥1.74 Billion | CN¥2.05 Billion | CN¥307.46 Million | ▼ -9.5 pp |
| 2020 | 94.5% | CN¥1.55 Billion | CN¥1.64 Billion | CN¥90.89 Million | ▲ +0.0 pp |
| 2019 | 94.4% | CN¥647.52 Million | CN¥685.78 Million | CN¥38.26 Million | ▼ 0.0 pp |
| 2018 | 94.4% | CN¥553.87 Million | CN¥586.45 Million | CN¥32.59 Million | ▲ +22.6 pp |
| 2017 | 71.9% | CN¥198.44 Million | CN¥276.06 Million | CN¥77.62 Million | ▼ -8.5 pp |
| 2016 | 80.3% | CN¥187.52 Million | CN¥233.39 Million | CN¥45.88 Million | — |